AU2003221532A1 - Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations - Google Patents
Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulationsInfo
- Publication number
- AU2003221532A1 AU2003221532A1 AU2003221532A AU2003221532A AU2003221532A1 AU 2003221532 A1 AU2003221532 A1 AU 2003221532A1 AU 2003221532 A AU2003221532 A AU 2003221532A AU 2003221532 A AU2003221532 A AU 2003221532A AU 2003221532 A1 AU2003221532 A1 AU 2003221532A1
- Authority
- AU
- Australia
- Prior art keywords
- belladonna
- epinastine
- pseudoephedrine
- combinations
- pharmaceutical formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241001106067 Atropa Species 0.000 title 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 title 1
- WHWZLSFABNNENI-UHFFFAOYSA-N epinastine Chemical compound C1C2=CC=CC=C2C2CN=C(N)N2C2=CC=CC=C21 WHWZLSFABNNENI-UHFFFAOYSA-N 0.000 title 1
- 229960003449 epinastine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 title 1
- 229960003908 pseudoephedrine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02007568.5 | 2002-04-03 | ||
| EP02007568A EP1350512A1 (en) | 2002-04-03 | 2002-04-03 | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
| PCT/EP2003/003263 WO2003082285A1 (en) | 2002-04-03 | 2003-03-28 | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003221532A1 true AU2003221532A1 (en) | 2003-10-13 |
Family
ID=27838061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003221532A Abandoned AU2003221532A1 (en) | 2002-04-03 | 2003-03-28 | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030228359A1 (enExample) |
| EP (2) | EP1350512A1 (enExample) |
| JP (1) | JP2005522467A (enExample) |
| AR (1) | AR039221A1 (enExample) |
| AU (1) | AU2003221532A1 (enExample) |
| BR (1) | BR0308982A (enExample) |
| CA (1) | CA2477751A1 (enExample) |
| MX (1) | MXPA04009582A (enExample) |
| PE (1) | PE20040080A1 (enExample) |
| PL (1) | PL371382A1 (enExample) |
| RU (1) | RU2004132205A (enExample) |
| WO (1) | WO2003082285A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
| US20030104017A1 (en) * | 2001-10-26 | 2003-06-05 | Boehringer Ingelheim International Gmbh | Epinastine formulation for oral administration |
| EP1591110B1 (en) * | 2003-01-22 | 2015-03-18 | Senju Pharmaceutical Co., Ltd. | Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye |
| CA2538023A1 (en) * | 2003-09-24 | 2005-04-07 | Combinatorx, Incorporated | Therapeutic regimens for administering drug combinations |
| WO2005074983A2 (en) * | 2004-02-06 | 2005-08-18 | Meda Pharma Gmbh & Co. Kg | Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids |
| JP4936420B2 (ja) * | 2005-08-02 | 2012-05-23 | 塩野義製薬株式会社 | 徐放性顆粒剤 |
| JP5162141B2 (ja) * | 2007-02-20 | 2013-03-13 | エスエス製薬株式会社 | フィルムコーティング用組成物 |
| RU2366446C1 (ru) * | 2008-06-27 | 2009-09-10 | Сергей Анатольевич Небера | Гомеопатическое средство для лечения конъюнктивитов |
| WO2010030418A1 (en) * | 2008-09-10 | 2010-03-18 | Micro-Dose Life Sciences Llc | Anti-fever botanical composition and uses thereof |
| CN102458117B (zh) * | 2009-05-01 | 2015-11-25 | 阿普塔利斯医药科技公司 | 含有非阿片样和阿片样止痛药的组合的口腔崩解片组合物 |
| JP5852816B2 (ja) * | 2010-09-10 | 2016-02-03 | ロート製薬株式会社 | 液状医薬組成物、及びこれを含有する軟カプセル剤 |
| RU2478377C1 (ru) * | 2011-08-08 | 2013-04-10 | Алексей Владимирович Брынцалов | Комбинированный препарат орвиум для устранения симптомов простудных заболеваний и гриппа |
| CN110237079B (zh) * | 2019-07-01 | 2021-05-14 | 山西大学 | 一种百部生物碱类似物的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10298107A (ja) * | 1997-04-25 | 1998-11-10 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
| US6613357B2 (en) * | 2000-01-13 | 2003-09-02 | Osmotica Corp. | Osmotic device containing pseudoephedrine and an H1 antagonist |
-
2002
- 2002-04-03 EP EP02007568A patent/EP1350512A1/en not_active Withdrawn
-
2003
- 2003-03-25 US US10/396,234 patent/US20030228359A1/en not_active Abandoned
- 2003-03-28 RU RU2004132205/15A patent/RU2004132205A/ru not_active Application Discontinuation
- 2003-03-28 BR BR0308982-7A patent/BR0308982A/pt not_active Application Discontinuation
- 2003-03-28 JP JP2003579822A patent/JP2005522467A/ja active Pending
- 2003-03-28 CA CA002477751A patent/CA2477751A1/en not_active Abandoned
- 2003-03-28 EP EP03717248A patent/EP1492532A1/en not_active Withdrawn
- 2003-03-28 AU AU2003221532A patent/AU2003221532A1/en not_active Abandoned
- 2003-03-28 MX MXPA04009582A patent/MXPA04009582A/es unknown
- 2003-03-28 WO PCT/EP2003/003263 patent/WO2003082285A1/en not_active Ceased
- 2003-03-28 PL PL03371382A patent/PL371382A1/xx unknown
- 2003-04-01 PE PE2003000332A patent/PE20040080A1/es not_active Application Discontinuation
- 2003-04-02 AR ARP030101144A patent/AR039221A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005522467A (ja) | 2005-07-28 |
| EP1350512A1 (en) | 2003-10-08 |
| EP1492532A1 (en) | 2005-01-05 |
| PE20040080A1 (es) | 2004-04-22 |
| BR0308982A (pt) | 2005-01-04 |
| PL371382A1 (en) | 2005-06-13 |
| RU2004132205A (ru) | 2005-09-10 |
| AR039221A1 (es) | 2005-02-09 |
| CA2477751A1 (en) | 2003-10-09 |
| WO2003082285A1 (en) | 2003-10-09 |
| US20030228359A1 (en) | 2003-12-11 |
| MXPA04009582A (es) | 2005-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002363236A1 (en) | Compounds, pharmaceutical compositions and methods of use therefor | |
| AU2003248721A1 (en) | Adsorbents, methods of preparation, and methods of use thereof | |
| AU2003273000A1 (en) | Stable solid preparations | |
| AU2003222347A1 (en) | Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof | |
| AU2003252299A1 (en) | Novel physiologically active substance | |
| AU2003284401A1 (en) | Cosmetic composition | |
| AU2003236135A1 (en) | Aralkyl-alcohol peiperazine derivatives and their uses as antidepressant | |
| AU2003220361A1 (en) | Benzamides and compositions benzamides for use as fungizide | |
| AU2003284595A1 (en) | Cosmetic hair preparation | |
| AU2003279911A1 (en) | Therapeutic formulations | |
| AU2003268771A1 (en) | Cosmetic pack preparation | |
| AU2003255645A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
| AU2003289742A1 (en) | Stable therapeutic proteins | |
| AU2003224747A1 (en) | Technetium-labeled rotenone derivatives, and methods of use thereof | |
| AU2003213345A1 (en) | Cosmetic preparation | |
| AU2003221532A1 (en) | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations | |
| AU2003269018A1 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
| AU2003296369A1 (en) | Imminoamines and preparation thereof | |
| AU2003222823A1 (en) | Physiologically compatible, phospholipid-containing, stable and hard matrix | |
| AU2003244942A1 (en) | Controlled-release pharmaceutical formulations | |
| AU2003292751A1 (en) | Hair care composition | |
| AU2003228651A1 (en) | Telescopic collimator and method of manufacture | |
| AU2003276844A1 (en) | Formulations of modified antibodies and methods of making the same | |
| AU2003250073A1 (en) | Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine | |
| AU2003301901A1 (en) | Cosmetic composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |